地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18327026838
邮箱:sales@amyjet.com
<艾美捷科技代理AxisPharm品牌全系列产品
AxisPharm是一家专业的分析服务提供商,致力于为科学研究界和工业界提供高质量的分析服务。凭借先进的仪器设备和专业的技术团队,AxisPharm在生物分析、化学分析和质量控制领域树立了良好的声誉。AxisPharm公司的产品线包括:PEG 连接子、用于药物递送的脂质、荧光染料、单击化学试剂、聚聚乙二醇,共聚物、可裂解的连接子、抗体和抗体药物偶联物ADC、ADC 有效载荷、细胞生物学试剂、脱氧核糖核酸、修饰语、探针、合成肽、目标特定链接器、硫醇反应性接头、酸反应性连接子、胺反应性连接子、羰基反应性连接子、探针、修饰符。

▍AxisPharm产品线
● PEG连接子:聚合物聚乙二醇是多分散聚乙二醇 (PEG) 聚合物,是一种从石油中提取的聚醚化合物,具有从工业制造到医药的许多应用。
● 用于药物递送的脂质:在药物递送系统中起着至关重要的作用,特别是在脂质体、脂质纳米颗粒或脂质胶束等脂质制剂中。脂质提供结构稳定性,增强药物溶解度,实现控释,并促进靶向药物递送。
● 荧光染料:也称为荧光团或荧光探针,是吸收一种波长的光并以更高波长发射的化合物,从而产生可见荧光。它们是生物学研究中的重要工具,用于标记和检测蛋白质、核酸和细胞等生物分子,从而在显微镜、流式细胞术和实时荧光定量 PCR 等应用中实现灵敏和精确的可视化。
● 点击化学试剂:具有高特异性和最少的副产物,简化了复杂的合成过程。因此,它们在分子生物学、材料科学和药物化学中发挥着至关重要的作用。
● 聚合物聚乙二醇:多分散聚乙二醇 (PEG) 聚合物,是一种从石油中提取的聚醚化合物,具有从工业制造到医药的许多应用。
● 可裂解连接子:一类重要的分子,广泛应用于药物发现、化学生物学和材料科学等各个领域。这些连接子充当两个或多个分子实体之间的连接桥,可以在特定条件下选择性地裂解,从而释放附着的分子。这一特性使它们成为生物活性化合物靶向药物递送、成像和控释的有吸引力的工具。
● 抗体及抗体-药物偶联物及细胞生物学试剂:种类丰富可选择。
● ADC有效载荷:作为 ADC 的三个主要成分之一,有效载荷是高活性和有毒的药物分子,通过化学连接子附着在抗体上。有效载荷可以是小分子、蛋白质毒素、生物活性肽、酶,甚至放射性核素。通过适当的接头与适当的载体系统耦合的有效载荷可能会显示出靶向药物递送的特异性和有效性的提高。
● 脱氧核糖核酸:DNA 是脱氧核糖核酸的缩写,是一种包含所有生物体发育和功能的遗传指令的分子。DNA 由四个基本组成部分组成,称为核苷酸,由糖、磷酸基团和含氮碱基组成。
● 改性剂:改变其他分子或材料特性的化合物。在药物研发领域,改性剂在新型药物递送系统和生物医学设备的设计和优化中发挥着至关重要的作用。一种常见的改性剂类型是官能团,它是赋予分子特定化学和物理性质的原子的特定排列。
● 探针:AxisPharm 提供各种靶标特异性探针,例如叶酸 PEG、生物素 PEG、PROTAC PEG、荧光染料探针和图像探针。探针是一类含有官能团的化合物,旨在选择性地与生物分子(如酶、受体和核酸)相互作用。这些官能团包括荧光染料、生物素和亲和标签等,可以检测和定量复杂生物系统中的特定分子。
| Different Types of Polyethylene Glycol PEG Linkers in Stock | ||||
| Acid PEG | Diketone PEG | Non-PEG linker | PFP ester PEG | Sugar PEG β-Glucuronide Linker |
| Aldehyde PEG | DNP PEG | PEG-t-butyl ester | Phosphonate PEG | Sulfonic acid PEG |
| Alkyne PEG | DBCO PEG | PEG-X-PEG | Polymer PEG | TCO PEG |
| Amino PEG | DSPE PEG | Peptide Linkers | Propargyl PEG | Tetrazine PEG |
| Aminooxy PEG | Fluorescent PEG | Lipid PEG | PROTAC Linker | Homobifunctional PEG |
| Azide PEG | Fmoc PEG | M-PEG | Silane PEG | Bromo PEG |
| BCN-PEG | Folate PEG | Maleimide PEG | SPDP PEG | Tosylate PEG |
| Benzyl-PEG | Thiol PEG | MeNH-PEG | Branched PEG | Bis-Sulfone PEG |
| Biotin PEG | Hydrazide PEG | NHS ester PEG | HyNic PEG | DOTA Reagent DOTA PEG |
| Bis-PEG-acid | Hydroxy PEG | Boc-PEG | Bis-PEG-NHS | Iodo PEG |
| Bis-PEG-NHS | Cleavable Linkers | |||
| Lipids for Drug Delivery | ||||
| Biotinyl Cap PE | Dodecanyl PE | Other Lipid | Phosphatidylcholine | Phosphatidylethanolamine |
| Biotinyl PE | Glutaryl PE | PDP PE | Phosphoglycerol | Ptd Thioethanol |
| Caproylamine PE | Ionizable Lipid | PE MCC | Phosphoserine | Succinyl PE |
| Cationic Lipid | Lipid PEG | Cyanur PE | MPB PE | |
| Fluorescent Dye | ||||
| AF Dyes | Cyanine Dyes | MB Dyes | Rhodamine Dye | Rox (carboxy-X-rhodamine) Dye |
| APDye Fluors | DNP PEG | JOE | R6G | Peptide Labeling Reagents |
| Bodipy Probes | Fluorescein (FAM) | Pyrene Probes | TAMRA Dye | Classic Fluorescent Dyes |
| IR Fluors | Quenchers | Coumarin 343 | ||
| Click Chemistry Tools & Reagents | ||||
| Alkyne PEG | BCN-PEG | PTAD Linker | Tetrazine PEG | Click Chemistry Auxiliary Reagents |
| Azide PEG | DBCO PEG | TCO PEG | Methylcyclopropene Linkers | |
| Polymer PEG | ||||
| Acrylate | Biotin | Fmoc | Lipoamide | Silane |
| Active ester | Boc | Folate | Maleimide | Stearic acid |
| Aldehyde | Carboxylic acid | guanlian1010 | MW 2000 | TCO |
| Amine | Cholesterol | Hydrazide | MW 5000 | Thiol |
| Azide | DBCO | Hydroxyl | Polysarcosine | |
| Cleavable Linkers | ||||
| -S-S-Cleavable | PC Cleavable | Disulfide Linkers | Dde Cleavable Linkers | β-Glucuronide Linkers |
| Cleavable Peptide | diazo biotin probes | DTSSP crosslinker | Photocleavable Biotin | |
| Antibody and Antibody Drug Conjugate (ADC) | ||||
| Inotuzumab | Trastuzumab | Enfortumab | Labetuzumab govitecan | Mirvetuximab soravtansine (solution) |
| Vobramitamab | Disitamab | Mirzotamab | Loncastuximab tesirine | Trastuzumab deruxtecan (solution) |
| Polatuzumab | Ozuriftamab | Brentuximab | Trastuzumab deruxtecan | ADC Control Human IgG1-Deruxtecan (DAR 8) |
| Gemtuzumab | Inebilizumab | Datopotamab | Cofetuzumab pelidotin | Glembatumumab vedotin |
| Daratumumab (PBS) | Denintuzumab | Sacituzumab govitecan | Belantamab mafodotin | Trastuzumab duocarmazine |
| Praluzatamab | Naratuximab | Tisotumab | Enfortumab vedotin-ejfv | Trastuzumab emtansine (solution) |
| Lorvotuzumab | Rolinsatamab | Trastuzumab emtansine | Telisotuzumab vedotin | Enfortumab vedotin-ejfv (solution) |
| Izeltabart | Mipasetamab | Datopotamab deruxtecan | Gemtuzumab ozogamicin | Brentuximab vedotin (solution) |
| Lupartumab | Iladatuzumab | ORM-5029 | Cantuzumab ravtansine | Depatuxizumab mafodotin |
| Cantuzumab | Briobacept | Ifinatamab deruxtecan | Tusamitamab ravtansine | ADC Control Human IgG1-Deruxtecan (DAR 4) |
| Lonigutamab | Tamrintamab | Tisotumab vedotin | Zilovertamab vedotin | Depatuxizumab MMAE |
| Moxetumomab | Sacituzumab | Disitamab vedotin | Polatuzumab vedotin | ADC Control Human IgG1-vcMMAF |
| Azintuxizumab | Upifitamab | Belantamab | Pivekimab | Sacituzumab govitecan (solution) |
| Lifastuzumab | Glembatumumab | Patritumab deruxtecan | Farletuzumab ecteribulin | |
| Payloads and Linker modified Payloads | ||||
| Exatecan | Belotecan HCl | SGD-1882 | Dolastatin 10 | MC-Val-Cit-PAB-Doxorubicin |
| SN 38 | Gimatecan | MMAF | Calicheamicin | Gly3-Val-Cit-PAB-MMAE |
| Amrubicin | Taltobulin | Auristatin E | Eribulin Mesylate | SuO-Glu-Val-Cit-PAB-MMAE |
| Mitomycin C | Dxd | Chlorambucil | Soblidotin (Auristatin PE) | Fmoc-G-amino-CH2O acetyl-Exetecan |
| Deruxtecan analog | Lurtotecan | PF-06380101 | Deruxtecan analog 2 | DM1-MCC-PEG3-Biotin |
| sulfo-SPDB-DM4 | Exatecan mesylate | Auristatin F | Paclitaxel | GGFG-amino-CH2O-acetyl Exetecan |
| Rubitecan | MC-DM1 | MMAF-methyl ester | MC-MMD10 | Mal-PEG8-Val-Cit-PAB-MMAE |
| (4-NH2)-Exatecan | Irinotecan | Doxorubicin-SMCC | SPDB-DM4 | DBCO-PEG4-Val-Cit-PAB MMAF |
| Topotecan | PNU-159682 | MMAD | 10-Hydroxycamptothecin | Topotecan Hydrochloride |
| CL2A-SN38 | DM4 | 7-Ethylcamptothecin | ||
| Cell Biology Reagents | ||||
| Neuro-DiO, lipophilic tracer | VU (5-Vinyl-uridine) | CM-DiI, lipophilic tracer | LumiTracker ER Green | ER-Tracker Red (BODIPY TR Glibenclamide) |
| Annexin V-AF 647 conjugate | DAPI, blue fluorescent nucleic acid stain | Propidium Iodide | Deep-Red Fluorescent Nissl Stain | MitoCLox, mitochondrial lipid peroxidation probe |
| Annexin V-AF 488 conjugate | LumiTracker Mito Rhodamine 123 | LumiTracker Mito Green FM | RAPID DiI, lipophilic tracer | Laurdan (6-Dodecanoyl-2-dimethylaminonaphthalene) |
| Annexin V, His Tag | Thiazole Orange | SynaptoProbe® Red | LumiTracker ER Red | Linear Polyacrylamide for Nucleic Acid Precipitation |
| DiD, lipophilic tracer | RH 237, potentiometric probe | SynaptoProbe® Green | RAPID DiO, lipophilic tracer | Fluo-4 AM, green fluorescent calcium indicator |
| DiR, lipophilic tracer | Hoechst 33342, blue fluorescent nucleic acid stain | LumiTracker® Mito Red FM | DiI, lipophilic tracer | YODi-1, green fluorescent nucleic acid stain |
| DNA | ||||
| CPG solid supports | DNA Stains | Modified Triphosphates | phosphoramidite | |
| Probes | ||||
| Biotin PEG | Folate PEG | Image Probes | PROTAC Linker | |
| Amine reactive Linkers | ||||
| Acid PEG | Aldehyde PEG | Bromo PEG | Maleimide PEG | NHS ester PEG |
▍AxisPharm提供的服务
● 蛋白质组学服务:提供质谱分析、蛋白质鉴定和定量服务。专注于生物标志物分析,帮助客户在复杂的生物样本中发现和验证潜在的生物标志物。
● 代谢组学服务:利用先进的LC-MS/MS技术进行代谢物分析,提供通路洞察,帮助客户理解代谢途径和生物过程。
● 高级LC-MS/MS服务:用于PK分析和HPLC分离,确保高精度和高效率的研究结果,提供PK/PD研究,支持药物开发和临床前研究。
▍AxisPharm部分产品列表
| Cat# | Name | M.W. | Purity |
| AP15197 | Exatecan | 435.45 | ≥98% |
| AP15072 | SN 38 | 392.4 | ≥95% |
| AP15226 | Amrubicin | 483.47 | ≥98% |
| AP15664 | Mitomycin C | 334.3 | ≥98% |
| AP15203 | 10-Hydroxycamptothecin | 364.35 | ≥95% |
| AP15204 | 7-Ethylcamptothecin | 376.41 | ≥95% |
| AP15210 | Rubitecan | 393.35 | ≥95% |
| AP15211 | (4-NH2)-Exatecan | 403.43 | ≥95% |
| AP15206 | Topotecan | 421.5 | ≥95% |
| AP15207 | Topotecan Hydrochloride | 425.5 | ≥95% |
| AP15202 | Belotecan HCl | 433.5 | ≥95% |
| AP15208 | Gimatecan | 447.5 | ≥95% |
| AP15227 | Taltobulin | 473.65 | ≥99% |
| AP15201 | Dxd | 493.48 | ≥95% |
| AP15209 | Lurtotecan | 518.56 | ≥95% |
| AP15196 | Exatecan mesylate | 531.55 | ≥98% |
| AP15200 | Deruxtecan analog 2 | 579.58 | ≥95% |
| AP15205 | Irinotecan | 586.68 | ≥95% |
| AP15224 | PNU-159682 | 641.62 | ≥98.24% |
| AP15220 | Soblidotin (Auristatin PE) | 701.98 | ≥95% |
| AP15225 | SGD-1882 | 725.8 | ≥98% |
| AP15213 | MMAF | 732 | ≥95% |
| AP15216 | Auristatin E | 732 | ≥95% |
| AP15311 | Chlorambucil | 304.21 | ≥98 |
| AP15219 | PF-06380101 | 743.01 | ≥95% |
| AP15214 | Auristatin F | 746 | ≥95% |
| AP15215 | MMAF-methyl ester | 745.99 | ≥98% |
| AP15187 | Doxorubicin-SMCC | 762.8 | ≥98% |
| AP15217 | MMAD | 771.06 | ≥98% |
invivoCrown IV0111替换BioXCell BE0036
invivoCrown IV0111替换BioXCell BE0036
invivoCrown IV0114替换BioXCell BE0213
<艾美捷科技代理Synthelis Biotech品牌全系列产品
Synthelis Biotech是一家法国公司,专注于蛋白质的生产、纯化与表征,公司致力于助力疫苗、生物制剂、酶、工程蛋白、诊断工具以及高通量分子或配体筛选技术的开发。Synthelis Biotech提供经过验证的蛋白质,其活性和纯度均根据特定应用(候选药物筛选、抗体与疫苗开发、结构生物学、体外诊断、蛋白质载体化)量身定制。Synthelis Biotech专利的无细胞技术使客户能够从不同蛋白家族(GPCRs、离子通道、转运蛋白等)和不同形式(蛋白脂质体、纳米盘、去垢剂溶解形式或可溶形式)中选择合适的蛋白质。凭借其专利技术,Synthelis 能够在数小时内合成各类蛋白质:包括膜蛋白、毒性蛋白、修饰蛋白等,应用于药物筛选、疫苗与抗体开发、结构生物学以及体外诊断等领域。同时可按需进行修饰(荧光或同位素标记、非天然氨基酸掺入、截短或突变形式等)。

▍Synthelis Biotech产品列表
| 分类 | 品名 | Protein | Origin | Format | Reference | Quantity | 分子量 |
| Viral Proteins | E1 | Envelop protein 1 | Hepatitis C virus | Proteoliposome | PL011 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 21 kDa |
| Viral Proteins | E2 | Envelop protein 1 | Hepatitis C virus | Proteoliposome | PL010 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 21 kDa |
| Viral Proteins | N-protein | Nucleocapsid Protein (COVID-19) | SARS-Cov 2 virus | Soluble | S-144 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 47,7 kDa |
| Viral Proteins | F5L | Vaccinia virus major membrane protein | Vaccinia virus | Proteoliposome | PL007 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 39.0 kDa |
| Viral Proteins | HCV p7 | Hepatitis C virus P7 | HCV virus | Proteoliposome | PL042 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 7 kDa |
| GPCRs | APJ/AR | Apelin Receptor | Human | Proteoliposome | PL061 | 10 µg, 50 µg ,100 µg | 44.7 kDa |
| GPCRs | B2R | Bradykinin receptor 2 | Human | Proteoliposome | PL080 | 10 µg, 50 µg ,100 µg | 47.0 kDa |
| GPCRs | BR | Bacteriorhodopsin | Bacteria | Proteoliposome | PL027 | 10 µg, 50 µg ,100 µg | 29.4 kDa |
| GPCRs | CCR1 | C-C chemokine receptor type 1 | Human | Proteoliposome | PL021 | 10 µg, 50 µg ,100 µg | 43.7 kDa |
| GPCRs | CCR2a | C-C chemokine receptor type 2, isoform a | Human | Proteoliposome | PL022 | 10 µg, 50 µg, 100 µg | 44.5 kDa |
| GPCRs | CCR2b | C-C chemokine receptor type 2, isoform b | Human | Proteoliposome | PL023 | 10µg, 20µg,100 µg, 200 µg | 42 kDa |
| GPCRs | CCR5 | C-C chemokine receptor type 5 | Human | Proteoliposome | PL024 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 40 kDa |
| GPCRs | CXCR4 | C-X-C chemokine receptor type 4 | Human | Proteoliposome | PL016 | 10 µg, 50 µg, 100 µg | 43 kDa |
| GPCRs | CXCR4-Detergent | C-X-C chemokine receptor type 4 | Human | Detergent | D016 | 25µg ,100 µg ,500 µg,bulk | 40 kDa |
| GPCRs | GLP1R | Glucagon-like peptide 1 receptor | Human | Proteoliposome | PL067 | 10 µg, 50 µg, 100 µg | 55.5 kDa |
| GPCRs | GPR50 | G-protein coupled receptor 50 | Human | Proteoliposome | PL095 | 10 µg, 50 µg, 100 µg | 67.4 kDa |
| GPCRs | GPR54 | G-protein coupled receptor 54 | Human | Proteoliposome | PL097 | 10 µg, 50 µg ,100 µg | 45.2 kDa |
| GPCRs | HMOP | Mu-type opioid receptor | Human | Proteoliposome | PL025 | - | - |
| GPCRs | MT1 | Melatonin receptor | Human | Proteoliposome | PL028 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 40 kDa |
| GPCRs | RXFP1 | Relaxin receptor 1 | Human | Proteoliposome | PL068 | 10 µg, 50 µg ,100 µg | 89.1 kDa |
| Ion Channels | kir1.1b | ATP-sensitive inward rectifier potassium channel 1 isoform b | Mouse | Proteoliposome | PL031 | 10µg, 20µg,100 µg, 200 µg, 500 µg, bulk | 42.7 kDa |
| Ion Channels | kv1.2 | Potassium voltage-gated channel subfamily A, member 2 | Rat | Proteoliposome | PL037 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 57 kDa |
| Ion Channels | kv1.3 | Potassium voltage-gated channel subfamily A, member 3 | Mouse | Proteoliposome | PL036 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 58 kDa |
| Ion Channels | VDAC1 | Voltage-Dependent Anion Channel 1 | Human | Proteoliposome | PL029 | 10 µg, 50 µg ,100 µg | 30.7kDa |
| Ion Channels | VDAC1 – Detergent | Voltage-Dependent Anion Channel 1 | Human | Detergent | D029 | 10 µg, 50 µg, 100 µg | 30.7kDa |
| Ligands | SDF1a | Stromal cell-derived factor 1 | Human | Soluble | S069 | 10 µg, 50 µg ,100 µg | 10.7 kDa |
| Porins | OEP24 | Outer envelope pore protein 24, chloroplastic | Plant | Proteoliposome | PL040 | 10 µg, 50 µg ,100 µg | 24 kDa |
| Porins | OprF | Outer membrane porin F | Bacteria | Proteoliposome | PL045 | 10 µg, 50 µg, 100 µg | 40 kDa |
| Enzymes | gp91phox (Nox2 subunit) | gp91phox | Human | Proteoliposome | PL008 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 55 kDa |
| Enzymes | KMO | Kynurenine 3-monooxygenase | Human | Proteoliposome | PL005 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 55,8 kDa |
| Enzymes | Nox2, p22 Phox | Cytochrome b-245 light chain | Human | Proteoliposome | PL039 | 10 µg, 50 µg ,100 µg | 23,5 kDa |
| Enzymes | Nox4 | Nox4 | Human | Proteoliposome | PL059 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 67 kDa |
| Enzymes | PORCN | Protein-Cysteine N-palmitoyltransferase porcupine | Human | Proteoliposome | PL006 | 10 µg, 50 µg, 100 µg | 55.5 kDa |
| Enzymes | TF | Tissue factor | Human | Proteoliposome | PL053 | 10µg, 20µg ,50µg, 100 µg , 200µg, 500 µg,bulk | 33 kDa |
| Enzymes | T7 RNA Pol | T7 RNA Polymerase | Bacteriophage T7 | Soluble | S192 | 10 µg, 50 µg, 100µg | 100.1 kDa |
| Enzymes | DsbC | Disulfide bond isomerase | E.coli | Soluble | S197 | customized quantity on request. | 25.4 kDa |
| Receptors | CLDN 18.2 | Claudin 18.2 Protein | Human | Proteoliposome | PL119 | 10 µg, 50 µg, 100 µg | 30 kDa |
| Transcriptional regulators | AROS | Active regulator of SIRT1 | Human | Proteoliposome | S052 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 15,4 kDa |
| Transporters | Bak | Bcl-2 homologous antagonist killer | Human | Proteoliposome | PL038 | 25µg ,100 µg ,500 µg,bulk | 17 kDa |
| Transporters | EspH | Cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli | Bacteria | Proteoliposome | PL051 | 10 µg, 50 µg, 100 µg | 21.9 kDa |
| Transporters | HCV p7 | Hepatitis C virus P7 | Virus | Proteoliposome | PL042 | 25µg ,100 µg ,500 µg,bulk | 7 kDa |
| Transporters | NhaA | Na(+)/H(+) antiporter NhaA | E. coli | Proteoliposome | PL032 | 10 µg, 50 µg, 100 µg | 43.9 kDa |
| Transporters | UCP1 | Mitochondrial brown fat uncoupling protein 1 | Mitochondria | Proteoliposome | PL047 | 10 µg, 50 µg, 100 µg | 35.1 kDa |
invivoCrown IV0113替换BioXCell BE0075
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0100替换BioXCell BE0146

Molecular Innovations公司为全球的研究人员提供高质量的科研产品,包括纤溶酶原激活物抑制因子1,肾素,肾素原,玻连蛋白,纤维蛋白,纤维连接蛋白,血纤维蛋白溶酶原,血纤维蛋白溶酶,抗凝血酶,ELISA试剂盒,抗体和其他研究使用的试剂。
Molecular Innovations, founded in 1990, is a primary manufacturer of research antibodies, proteins and ELISA kits. We specialize in coagulation and thrombolysis reagents including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, clotting factors, prorenin/renin, albumin, and immunoglobulins. Our customers all over the world include pharmaceutical and biotechnology companies as well as major research institutions. We offer custom projects and bulk quotes. All products are manufactured under stringent quality control standards at our new state of the art facility in Novi, MI, USA.
Molecular innovations的主要产品包括:
Research Models
Molecular Biology
Purified Proteins
Elisa Kits
Monoclonal Antibodies
Polyclonal Antibodies
Inhibitors And Substrates
Chromatography Resins
Plasmas And Tissues
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
invivoCrown IV0110替换BioXCell BE0058
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:15172469628
邮箱:sales@amyjet.com
0.1437